These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 30975903)
21. Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress. Xu R; Yuan Z; Yang L; Li L; Li D; Lv C Oncol Rep; 2017 Sep; 38(3):1767-1773. PubMed ID: 28714034 [TBL] [Abstract][Full Text] [Related]
22. NAMPT pathway is involved in the FOXO3a-mediated regulation of GADD45A expression. Thakur BK; Lippka Y; Dittrich T; Chandra P; Skokowa J; Welte K Biochem Biophys Res Commun; 2012 Apr; 420(4):714-20. PubMed ID: 22430142 [TBL] [Abstract][Full Text] [Related]
23. Nicotinamide phosphoribosyltransferase postpones rat bone marrow mesenchymal stem cell senescence by mediating NAD Pi C; Yang Y; Sun Y; Wang H; Sun H; Ma M; Lin L; Shi Y; Li Y; Li Y; He X Aging (Albany NY); 2019 Jun; 11(11):3505-3522. PubMed ID: 31175267 [No Abstract] [Full Text] [Related]
27. Nampt and its potential role in inflammation and type 2 diabetes. Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571 [TBL] [Abstract][Full Text] [Related]
28. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Nakahata Y; Sahar S; Astarita G; Kaluzova M; Sassone-Corsi P Science; 2009 May; 324(5927):654-7. PubMed ID: 19286518 [TBL] [Abstract][Full Text] [Related]
29. Identification of small-molecule urea derivatives as novel NAMPT inhibitors via pharmacophore-based virtual screening. Ozgencil F; Eren G; Ozkan Y; Guntekin-Ergun S; Cetin-Atalay R Bioorg Med Chem; 2020 Jan; 28(1):115217. PubMed ID: 31818629 [TBL] [Abstract][Full Text] [Related]
30. Up-regulation of nicotinamide phosphoribosyltransferase and increase of NAD+ levels by glucose restriction extend replicative lifespan of human fibroblast Hs68 cells. Yang NC; Song TY; Chang YZ; Chen MY; Hu ML Biogerontology; 2015 Feb; 16(1):31-42. PubMed ID: 25146190 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress. Sharma P; Xu J; Williams K; Easley M; Elder JB; Lonser R; Lang FF; Lapalombella R; Sampath D; Puduvalli VK Neuro Oncol; 2022 Feb; 24(2):229-244. PubMed ID: 34260721 [TBL] [Abstract][Full Text] [Related]
32. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer. Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976 [TBL] [Abstract][Full Text] [Related]
33. Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. Bruzzone S; Fruscione F; Morando S; Ferrando T; Poggi A; Garuti A; D'Urso A; Selmo M; Benvenuto F; Cea M; Zoppoli G; Moran E; Soncini D; Ballestrero A; Sordat B; Patrone F; Mostoslavsky R; Uccelli A; Nencioni A PLoS One; 2009 Nov; 4(11):e7897. PubMed ID: 19936064 [TBL] [Abstract][Full Text] [Related]
34. Nicotinamide phosphoribosyltransferase‑related signaling pathway in early Alzheimer's disease mouse models. Xing S; Hu Y; Huang X; Shen D; Chen C Mol Med Rep; 2019 Dec; 20(6):5163-5171. PubMed ID: 31702813 [TBL] [Abstract][Full Text] [Related]
35. Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment. Borradaile NM; Pickering JG Aging Cell; 2009 Apr; 8(2):100-12. PubMed ID: 19302375 [TBL] [Abstract][Full Text] [Related]
37. EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells. Mutz CN; Schwentner R; Aryee DNT; Bouchard EDJ; Mejia EM; Hatch GM; Kauer MO; Katschnig AM; Ban J; Garten A; Alonso J; Banerji V; Kovar H Oncotarget; 2017 Apr; 8(15):24679-24693. PubMed ID: 28160567 [TBL] [Abstract][Full Text] [Related]
38. Divergent metabolic responses dictate vulnerability to NAMPT inhibition in ovarian cancer. Kudo K; Nomura M; Sakamoto Y; Ito S; Morita M; Kawai M; Yamashita Y; Ito K; Yamada H; Shima H; Yaegashi N; Tanuma N FEBS Lett; 2020 May; 594(9):1379-1388. PubMed ID: 31950503 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications. Tan B; Young DA; Lu ZH; Wang T; Meier TI; Shepard RL; Roth K; Zhai Y; Huss K; Kuo MS; Gillig J; Parthasarathy S; Burkholder TP; Smith MC; Geeganage S; Zhao G J Biol Chem; 2013 Feb; 288(5):3500-11. PubMed ID: 23239881 [TBL] [Abstract][Full Text] [Related]
40. Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes. Pittelli M; Cavone L; Lapucci A; Oteri C; Felici R; Niccolai E; Amedei A; Chiarugi A Immunol Cell Biol; 2014 Feb; 92(2):191-9. PubMed ID: 24275857 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]